Skip to main content
. 2017 May 23;6(6):1201–1219. doi: 10.1002/cam4.1071

Table 4.

Grade 3/4 toxicity for each group

Group Grade 3/4 Toxicity
All patients [95% CI] 11.3% [9.1, 3.9%]
I 2  = 48.5%
(= 32)
Monotherapy [95% CI] 6.7% [3.4, 12.7%]
I 2  = 48.6%
(= 9)
Combination therapy [95% CI] 12.3% [9.8, 15.3%]
I 2  = 48.3% (= 23)